Basics
Ofloxacin is an antibiotic used to treat bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.
Es wird weitgehend äußerlich als Augen- und Ohrentropfen eingesetzt.
ATC Code | J01MA01, S01AE01, S02AA16 |
CAS number | 82419-36-1 |
PUB number | 4583 |
Drugbank ID | DB01165 |
Empirical formula | C18H20FN3O4 |
Molar mass (g·mol−1) | 361,4 |
Physical state | solid |
Melting point (°C) | 254 |
PKS value | 5,35 |
Ofloxacin is an antibiotic used to treat bacterial infections in many parts of the body, including the respiratory tract, kidney, skin, soft tissue, and urinary tract.
Es wird weitgehend äußerlich als Augen- und Ohrentropfen eingesetzt.
Ofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. Its mode of action depends on blocking bacterial DNA replication (duplication) by binding itself to an enzyme called DNA gyrase. This enzyme allows the untwisting of the DNA double helix, which is necessary to replicate it into two.
Das Medikament hat eine 100-mal höhere Affinität für die bakterielle DNA-Gyrase als für die von Säugetieren.
The bioavailability in the tablet formulation is approximately 98%.
32% des Medikaments werden an Plasmaproteine gebunden.
Das Arzneimittel wird hauptsächlich renal ausgeschieden, wobei zwischen 65% und 80% einer verabreichten oralen Ofloxacin-Dosis innerhalb von 48 Stunden nach der Einnahme unverändert über den Urin ausgeschieden werden. Etwa 4-8 % einer Ofloxacin-Dosis werden mit den Fäzes ausgeschieden, das Arzneimittel unterliegt nur einer minimalen biliären Ausscheidung.
Ofloxacin may interact with other drugs. Co-administration of some fluoroquinolone anti-infectives (e.g., ciprofloxacin, norfloxacin, ofloxacin) in patients taking theophylline may result in higher and prolonged serum theophylline concentrations, potentially increasing the risk of theophylline-related adverse reactions. The magnitude of this interaction varies considerably among commercially available fluoroquinolones; the effect is less pronounced with norfloxacin or ofloxacin than with ciprofloxacin.
Concomitant use of a fluoroquinolone with fenbufen (a nonsteroidal anti-inflammatory agent) may increase the risk of CNS stimulation (e.g., seizures).
Oral multivitamin and mineral supplements containing, for example, iron or zinc may decrease the oral absorption of ofloxacin, resulting in decreased serum concentrations of quinolone. Therefore, these multivitamins and/or mineral supplements should not be taken concomitantly with or within 2 hours of an ofloxacin dose.
In addition, the drug should not be taken with caffeinated beverages or foods, if possible.
Adverse reactions include local reactions such as stinging, pain, hypersensitivity reactions, and rarely deposits.
Möglich, aber selten, sind systemische Nebenwirkungen wie allergische Reaktionen sowie Geruchs- und Geschmacksstörungen.
Bei 1 bis 2 % der mit Ofloxacin behandelten Patienten treten leichte Erhöhungen des ALT- und des alkalischen Phosphatasespiegel auf. Diese meist asymptomatischen Begleiterscheinungen klingen von selbst bei Fortsetzung der Therapie ab.
In rare cases, ofloxacin has been associated with acute liver injury.
LD50 (rat, oral): 5450 mg/kg.
Markus Falkenstätter, BSc
Mag. pharm. Stefanie Lehenauer
Browse our extensive database of medications from A-Z, including effects, side effects, and dosage.
All active ingredients with their effects, applications, and side effects, as well as the medications they are contained in.
Symptoms, causes, and treatments for common diseases and injuries.
The presented content does not replace the original package insert of the medication, especially regarding the dosage and effects of individual products. We cannot assume liability for the accuracy of the data, as the data has been partially converted automatically. Always consult a doctor for diagnoses and other health-related questions.
© medikamio